Enanta Pharmaceuticals
ENTA
$12.37
Share price
-0.88%
Change (1 day)
-65.20%
Change (1 year)
Categories
Enanta Pharmaceuticals (ENTA) - Total debt
Total debt on the balance sheet as of December 2023 : $25.49 M
According to Enanta Pharmaceuticals 's latest financial reports the company's total debt is $25.49 M. A company’s total debt is the sum of all current and non-current debts.
Enanta Pharmaceuticals - Total debt on balance sheet (from 2014 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-09-30 | $26.51 M | 4.95% |
| 2022-09-30 | $25.26 M | 374.07% |
| 2021-09-30 | $5.32 M | -34.2% |
| 2020-09-30 | $8.09 M | 3949.5% |
| 2019-09-30 | $0.2 M | -31.74% |
| 2018-09-30 | $0.29 M | -22.69% |
| 2017-09-30 | $0.37 M | -28.63% |
| 2016-09-30 | $0.53 M | -11.2% |
| 2015-09-30 | $0.59 M | |
| 2014-09-30 | $N/A |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $29.33 B | 114,972.58% | 🇺🇸 USA |
 Novartis NVS | $27.28 B | 106,938.05% | 🇨🇭 Switzerland |
 AbbVie ABBV | $59.38 B | 232,873.72% | 🇺🇸 USA |
 Vertex Pharmaceuticals VRTX | $0.80 B | 3,071.44% | 🇺🇸 USA |
 Merck MRK | $35.05 B | 137,424.52% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $57.40 B | 225,121.66% | 🇺🇸 USA |